Paul George Will Miss Wednesday's Preseason Clash with Bronchitis

Use your ← → (arrow) keys to browse more stories
Paul George Will Miss Wednesday's Preseason Clash with Bronchitis
Bill Baptist/Getty Images

The Indiana Pacers will be without their top star for Wednesday's preseason matchup against the Dallas Mavericks, as Paul George tries to recover from illness. Scott Agness of shared the details of George's condition as of Tuesday afternoon:

The 104-degree fever is obviously concerning, but it's even more concerning for the Pacers since George is their franchise player. Bronchitis can linger, and the team also has upcoming road preseason games on Friday and Saturday, so it will be interesting to see how fast George can make a recovery.   

Without George or Roy Hibbert, the team's starting center, Agness provided a predicted starting lineup for Indiana:

George's illness comes on the heels of the team's week-long trip Asia for the NBA's Global Games series. The Pacers played the Houston Rockets in the Philippines and Taiwan last week before heading back to Indiana on Sunday night:

George made his first All-Star team last season by posting career highs in points (17.4), rebounds (7.3) and assists (4.1) per game in his third year out of Fresno State. He's also becoming the most visible member of the Pacers, even being featured as the first player shown in the NBA's commercial for the upcoming season:

With George leading the attack, the Pacers figure to be one of the best teams in the Eastern Conference again for the 2013-14 season. Indiana finished as the No. 3 seed in the East last year before taking the eventual champion Miami Heat to seven games in the Conference Finals. George shined in the series.

If a player is going to be sidelined with something in the preseason, it's generally better that it's an illness rather than an injury. With 14 days left until the regular season, George should have ample time to recover for the opener against the Orlando Magic.

Follow B/R on Facebook


Subscribe Now

By signing up for our newsletter, you agree to our Terms and Privacy Policy.

Thanks for signing up.